Clinical Trial Update: Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating iparomlimab and tuvonralimab in combination with paclitaxel and cisplatin for cervical cancer; currently recruiting. No res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Obstetrics & Gynecology Hospital of Fudan University | Conditions: Cervical Cancers | Phase 2 | Status: RECRUITING